Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regorafenib in older adults with metastatic colorectal cancer
NCT02466009Phase 2Completed
- Sponsor
- University of Rochester
- Start
- Mar 2015
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of regorafenib in metastatic colorectal cancer (mCRC), sponsored by University of Rochester. Started Mar 2015; status: completed.
02
Drugs
regorafenib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT02466009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02466009.